Target Aktie
WKN: 856243 / ISIN: US87612E1064
16.11.2023 09:33:27
|
Kilitch Healthcare Recalls Eye Drops Sold Through Walmart, Target, CVS
(RTTNews) - Mumbai, Maharashtra-based Kilitch Healthcare India Ltd. is recalling various eye drops under multiple labels sold through Walmart, Target, and CVS due to potential safety concerns, according to the U.S Food and Drug Administration or FDA.
The recall was initiated when the agency investigators found insanitary conditions.
The recall involves all lots within expiry with expiration dates ranging from November, 2023 to September, 2025.
The called-back products were distributed nationwide to wholesalers, retailers and via product distributor, Velocity Pharma LLC.
The affected lubricant eye drops & multi-symptom eye drops were sold through various retailers and labels including Walmart, Rugby, Target, Rite Aid, Leader, Velocity and CVS.
The patients who used these impacted products run a potential risk of eye infections or related harm. These products are intended to be sterile and such ophthalmic drug products may pose heightened risk of harm because drugs applied to the eyes bypass some of the body's natural defenses.
So far, the pharmaceutical company has not received any reports of adverse events related to the recall.
FDA is urging the consumers to stop using the recalled eye drops and instead return to the place of purchase.
In similar recalls, Cardinal Health, Inc. earlier this month recalled certain Leader branded eye drops supplied by Velocity Pharma citing potential risk of eye infections.
Phoenix, Arizona-based Pharmedica USA LLC in March recalled Purely Soothing, 15 percent MSM eye drops to the consumer level due to non-sterility.
In mid- September, the FDA had warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law.
For More Such Health News, visit rttnews.com

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Walmartmehr Nachrichten
02.04.25 |
Dow Jones 30 Industrial-Papier Walmart-Aktie: So viel Gewinn hätte ein Investment in Walmart von vor einem Jahr eingefahren (finanzen.at) | |
01.04.25 |
Börse New York: Dow Jones zeigt sich zum Ende des Dienstagshandels leichter (finanzen.at) | |
01.04.25 |
Schwacher Handel in New York: Dow Jones präsentiert sich schwächer (finanzen.at) | |
01.04.25 |
Freundlicher Handel in New York: Dow Jones am Dienstagmittag mit Zuschlägen (finanzen.at) | |
01.04.25 |
Minuszeichen in New York: Dow Jones zum Handelsstart in Rot (finanzen.at) | |
31.03.25 |
Montagshandel in New York: Schlussendlich Pluszeichen im Dow Jones (finanzen.at) | |
31.03.25 |
Optimismus in New York: Am Nachmittag Pluszeichen im Dow Jones (finanzen.at) | |
31.03.25 |
Montagshandel in New York: Das macht der Dow Jones am Montagmittag (finanzen.at) |
Analysen zu Walmartmehr Analysen
07:54 | Walmart Outperform | RBC Capital Markets | |
31.03.25 | Walmart Buy | UBS AG | |
25.03.25 | Walmart Buy | Jefferies & Company Inc. | |
24.02.25 | Walmart Kaufen | DZ BANK | |
21.02.25 | Walmart Buy | UBS AG |
Aktien in diesem Artikel
CVS Health Corp | 58,09 | -5,74% |
|
Target Corp. | 87,19 | 2,69% |
|
Walmart | 75,82 | -4,18% |
|